HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark A Ator Selected Research

6- (4- (3- (2- methylpyrrolidin- 1- yl)propoxy)phenyl)- 2H- pyridazin- 3- one

1/2012CEP-26401 (irdabisant), a potent and selective histamine H₃ receptor antagonist/inverse agonist with cognition-enhancing and wake-promoting activities.
7/2011Discovery and characterization of 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, irdabisant): a potent, selective histamine H3 receptor inverse agonist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark A Ator Research Topics

Disease

11Neoplasms (Cancer)
02/2015 - 12/2003
3Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
03/2012 - 02/2006
2Schizophrenia (Dementia Praecox)
01/2012 - 11/2010
1Migraine Disorders (Migraine)
01/2020
1Basal Cell Carcinoma (Rodent Ulcer)
11/2017
1Inflammation (Inflammations)
10/2016
1Multiple Sclerosis
10/2016
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2016
1Chronic Progressive Multiple Sclerosis
10/2016
1Demyelinating Diseases (Demyelinating Disease)
10/2016
1Huntington Disease (Huntington's Disease)
10/2016
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/2016
1Sleep Wake Disorders
01/2016
1Neoplasm Metastasis (Metastasis)
02/2015
1Acquired Immunodeficiency Syndrome (AIDS)
10/2012
1Melanoma (Melanoma, Malignant)
04/2012
1Colorectal Neoplasms (Colorectal Cancer)
04/2012
1Acute Erythroblastic Leukemia (Erythroleukemia)
04/2012
1Hyperplasia
04/2012
1Carcinoma (Carcinomatosis)
04/2012
1Neuroblastoma
03/2012
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2012
1Genetic Translocation (Chromosomal Translocation)
03/2012
1Sarcoma (Soft Tissue Sarcoma)
02/2012
1Splenomegaly
10/2011
1Lupus Nephritis
10/2011
1Cognitive Dysfunction
07/2011
1Rheumatoid Arthritis
04/2011
1Body Weight (Weight, Body)
04/2011
1Autoimmune Diseases (Autoimmune Disease)
04/2011
1Arthritis (Polyarthritis)
04/2011
1Multiple Myeloma
02/2008
1Leukemia
02/2006

Drug/Important Bio-Agent (IBA)

6Pharmaceutical PreparationsIBA
01/2020 - 03/2012
4Anaplastic Lymphoma KinaseIBA
05/2012 - 02/2006
3Proteins (Proteins, Gene)FDA Link
04/2012 - 02/2006
2Tyrosine (L-Tyrosine)FDA Link
06/2012 - 03/2012
2Proteasome Endopeptidase Complex (Proteasome)IBA
05/2012 - 04/2012
2ChymotrypsinFDA Link
05/2012 - 04/2012
2agerafenibIBA
04/2012 - 02/2012
2Proteasome InhibitorsIBA
04/2012 - 02/2008
2CytokinesIBA
01/2012 - 04/2011
26- (4- (3- (2- methylpyrrolidin- 1- yl)propoxy)phenyl)- 2H- pyridazin- 3- oneIBA
01/2012 - 07/2011
2CEP 33779IBA
10/2011 - 04/2011
1oxazine 1IBA
01/2020
1piperidineIBA
01/2020
1Calcitonin Gene-Related Peptide Receptor AntagonistsIBA
01/2020
1Transcription Factors (Transcription Factor)IBA
11/2017
1Histone Deacetylase 1IBA
11/2017
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
10/2016
1Myelin-Oligodendrocyte GlycoproteinIBA
10/2016
1laquinimodIBA
10/2016
13- (1'- cyclobutylspiro(4H- 1,3- benzodioxine- 2,4'- piperidine)- 6- yl)- 5,5- dimethyl- 1,4- dihydropyridazin- 6- oneIBA
01/2016
1Biological ProductsIBA
02/2015
1AcrylonitrileIBA
02/2015
1Phosphotransferases (Kinase)IBA
06/2012
1CrizotinibIBA
05/2012
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
04/2012
1MitogensIBA
04/2012
1Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA
04/2012
1CEP-28122IBA
03/2012
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2012
1Antipsychotic Agents (Antipsychotics)IBA
01/2012
1Histamine (Histamine Dihydrochloride)FDA Link
07/2011
1InterferonsIBA
04/2011
1InterleukinsIBA
04/2011
1Dihydrotachysterol (AT 10)IBA
04/2011
1CollagenIBA
04/2011
1AutoantibodiesIBA
04/2011
1Interleukin-12 (IL 12)IBA
04/2011
1Janus Kinase InhibitorsIBA
04/2011
1Collagen Type II (Type II Collagen)IBA
04/2011
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
04/2011
1Janus Kinase 2IBA
04/2011
1EnzymesIBA
12/2010
1Insulin ReceptorIBA
12/2010
1Glycine (Aminoacetic Acid)FDA LinkGeneric
11/2010
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
11/2010
1N-Methylaspartate (NMDA)IBA
11/2010
1Glycine Plasma Membrane Transport ProteinsIBA
11/2010
1Bortezomib (Velcade)FDA Link
02/2008
1dimethylglycineIBA
12/2003
1compound 21IBA
12/2003
1EstersIBA
12/2003
1ProdrugsIBA
12/2003

Therapy/Procedure

5Therapeutics
05/2012 - 01/2012
2Oral Administration
04/2012 - 04/2011